{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:15:43Z","timestamp":1790223343480,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T00:00:00Z","timestamp":1522886400000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Families belonging to the GFB Italian Onlus"},{"name":"Center for Clinical and Translational Science voucher program at The Ohio State University Wexner Medical Center","award":["UL1TR001070"],"award-info":[{"award-number":["UL1TR001070"]}]},{"name":"Nationwide Children\u2019s Hospital Foundation"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ymthe.2017.02.013","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T02:47:15Z","timestamp":1489027635000},"page":"855-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Systemic AAV-Mediated \u03b2-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Eric R.","family":"Pozsgai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin N.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry R.","family":"Mendell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise R.","family":"Rodino-Klapac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.02.013_bib1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.jnen.0000235854.77716.6c","article-title":"Limb-girdle muscular dystrophy in the United States","volume":"65","author":"Moore","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ng1195-266","article-title":"Beta-sarcoglycan\u00a0(A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex","volume":"11","author":"B\u00f6nnemann","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.02.013_bib3","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/5.12.1953","article-title":"Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E)","volume":"5","author":"B\u00f6nnemann","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.02.013_bib4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/hmg\/8.9.1589","article-title":"Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice","volume":"8","author":"Araishi","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.02.013_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1097-2765(00)80410-4","article-title":"Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E","volume":"5","author":"Durbeej","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2017.02.013_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.52.1.176","article-title":"The clinical spectrum of sarcoglycanopathies","volume":"52","author":"Angelini","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2017.02.013_bib7","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1017\/S1462399409001203","article-title":"Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects","volume":"11","author":"Sandon\u00e0","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymthe.2017.02.013_bib8","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.0000000000001519","article-title":"Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E","volume":"84","author":"Semplicini","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2017.02.013_bib9","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1152\/japplphysiol.01357.2003","article-title":"Progression of kyphosis in mdx mice","volume":"97","author":"Laws","year":"2004","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2017.02.013_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/humu.9357","article-title":"Homozygous microdeletion of chromosome 4q11-q12 causes severe limb-girdle muscular dystrophy type 2E with joint hyperlaxity and contractures","volume":"26","author":"Kaindl","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2017.02.013_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0960-8966(00)00174-7","article-title":"Evaluation of cardiac and respiratory involvement in sarcoglycanopathies","volume":"11","author":"Politano","year":"2001","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2017.02.013_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0960-8966(02)00280-8","article-title":"LGMD2E patients risk developing dilated cardiomyopathy","volume":"13","author":"Fanin","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2017.02.013_bib14","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archneur.65.9.1196","article-title":"Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy","volume":"65","author":"Sveen","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/(SICI)1097-4598(199904)22:4<473::AID-MUS8>3.0.CO;2-5","article-title":"Heart involvement in muscular dystrophies due to sarcoglycan gene mutations","volume":"22","author":"Melacini","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2017.02.013_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jmg.37.2.102","article-title":"Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations","volume":"37","author":"Barresi","year":"2000","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ymthe.2017.02.013_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00441-014-1854-4","article-title":"Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse","volume":"356","author":"Gibertini","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymthe.2017.02.013_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/gt.2015.80","article-title":"\u03b2-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice","volume":"23","author":"Pozsgai","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib19","doi-asserted-by":"crossref","first-page":"e000284","DOI":"10.1161\/JAHA.113.000284","article-title":"Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice","volume":"2","author":"Quattrocelli","year":"2013","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.ymthe.2017.02.013_bib20","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in\u00a0vivo","volume":"10","author":"McCarty","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/mt.2013.246","article-title":"Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin alpha2 surrogates","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/mt.2009.254","article-title":"Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery","volume":"18","author":"Rodino-Klapac","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/mt.2013.244","article-title":"Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.0000000000000892","volume":"83","author":"Narayanaswami","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2017.02.013_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinph.2006.10.018","article-title":"Experienced and physiological fatigue in neuromuscular disorders","volume":"118","author":"Schillings","year":"2007","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jpsychores.2006.11.014","article-title":"The development of a model of fatigue in neuromuscular disorders: a longitudinal study","volume":"62","author":"Kalkman","year":"2007","journal-title":"J.\u00a0Psychosom. Res."},{"key":"10.1016\/j.ymthe.2017.02.013_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature07414","article-title":"Sarcolemma-localized nNOS is required to maintain activity after mild exercise","volume":"456","author":"Kobayashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.02.013_bib30","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.ajpath.2011.07.009","article-title":"mdx(5cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice","volume":"179","author":"Beastrom","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1479-5876-5-45","article-title":"A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy","volume":"5","author":"Rodino-Klapac","year":"2007","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ymthe.2017.02.013_bib32","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/gt.2008.104","article-title":"Construction and analysis of compact muscle-specific promoters for AAV vectors","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000306309.85301.e2","article-title":"Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D","volume":"71","author":"Rodino-Klapac","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2017.02.013_bib34","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1093\/hmg\/ddt112","article-title":"Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy","volume":"22","author":"Wasala","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.02.013_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ppul.22847","article-title":"Respiratory muscle decline in Duchenne muscular dystrophy","volume":"49","author":"Khirani","year":"2014","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib36","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/(SICI)1097-4598(199809)21:9<1153::AID-MUS6>3.0.CO;2-6","article-title":"Dystrophy and myogenesis in mdx diaphragm muscle","volume":"21","author":"Anderson","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2017.02.013_bib37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nmd.2008.02.002","article-title":"Mdx respiratory impairment following fibrosis of the diaphragm","volume":"18","author":"Ishizaki","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2017.02.013_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-3-319-18440-1_27","article-title":"Respiratory Control in the mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"860","author":"Burns","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/hmg\/ddi072","article-title":"Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy","volume":"14","author":"Imamura","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.02.013_bib40","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1172\/JCI11642","article-title":"Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex","volume":"107","author":"Cohn","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2017.02.013_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0008-6363(97)00227-7","article-title":"Preserved Frank-Starling mechanism in human end stage heart failure","volume":"37","author":"Weil","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"1 Pt 2 Su","key":"10.1016\/j.ymthe.2017.02.013_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0002-8703(96)90558-X","article-title":"The role of neurohormonal activation in chronic heart failure and postmyocardial infarction","volume":"132","author":"Sigurdsson","year":"1996","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ymthe.2017.02.013_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2016.05.008","article-title":"Diastolic dysfunction and cardiac troponin I decrease in aging hearts","volume":"603","author":"Pan","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymthe.2017.02.013_bib44","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1016\/S1525-0016(16)33289-0","article-title":"Gene Therapy for Spinal Muscular Atrophy Type 1 Shows Potential to Improve Survival and Motor Functional Outcomes","volume":"24","author":"Mendell","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib45","unstructured":"Mendell, J.R. (2014). Phase I Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 Delivering AVXS-101. http:\/\/adisinsight.springer.com\/trials\/700246826."},{"key":"10.1016\/j.ymthe.2017.02.013_bib46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acn3.172","article-title":"AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models","volume":"2","author":"Sondergaard","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2017.02.013_bib48","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/nprot.2006.207","article-title":"Production and characterization of adeno-associated viral vectors","volume":"1","author":"Grieger","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2017.02.013_bib49","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/10430349950018427","article-title":"Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses","volume":"10","author":"Clark","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.02.013_bib50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice","volume":"124","author":"Rafael-Fortney","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2017.02.013_bib51","first-page":"e50036","article-title":"Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies","volume":"71","author":"Moorwood","year":"2013","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2017.02.013_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1601-183X.2004.00106.x","article-title":"Long-term individual housing in C57BL\/6J and DBA\/2 mice: assessment of behavioral consequences","volume":"4","author":"V\u00f5ikar","year":"2005","journal-title":"Genes Brain Behav."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617300904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617300904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:28:56Z","timestamp":1717828136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617300904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1525001617300904"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.02.013","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic AAV-Mediated \u03b2-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}